Literature DB >> 16179440

Infectious disease. Old drugs losing effectiveness against flu; could statins fill gap?

Martin Enserink.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16179440     DOI: 10.1126/science.309.5743.1976a

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  11 in total

1.  Effect of statin treatments on highly pathogenic avian influenza H5N1, seasonal and H1N1pdm09 virus infections in BALB/c mice.

Authors:  Yohichi Kumaki; John D Morrey; Dale L Barnard
Journal:  Future Virol       Date:  2012-08       Impact factor: 1.831

2.  Increased survival after gemfibrozil treatment of severe mouse influenza.

Authors:  Alison Budd; Lisa Alleva; Mohammed Alsharifi; Aulikki Koskinen; Victoria Smythe; Arno Müllbacher; Jeff Wood; Ian Clark
Journal:  Antimicrob Agents Chemother       Date:  2007-06-11       Impact factor: 5.191

Review 3.  New treatments for influenza.

Authors:  Sailen Barik
Journal:  BMC Med       Date:  2012-09-13       Impact factor: 8.775

4.  A Canadian Critical Care Trials Group project in collaboration with the international forum for acute care trialists - Collaborative H1N1 Adjuvant Treatment pilot trial (CHAT): study protocol and design of a randomized controlled trial.

Authors:  Karen E A Burns; Clarence Chant; Orla Smith; Brian Cuthbertson; Robert Fowler; Deborah J Cook; Peter Kruger; Steve Webb; Jamal Alhashemi; Guillermo Dominguez-Cherit; Carlos Zala; Gordon D Rubenfeld; John C Marshall
Journal:  Trials       Date:  2011-03-09       Impact factor: 2.279

Review 5.  Mechanisms of action and efficacy of statins against influenza.

Authors:  Parvaneh Mehrbod; Abdul Rahman Omar; Mohd Hair-Bejo; Amin Haghani; Aini Ideris
Journal:  Biomed Res Int       Date:  2014-11-11       Impact factor: 3.411

Review 6.  Response Modifiers: Tweaking the Immune Response Against Influenza A Virus.

Authors:  Husni Elbahesh; Thomas Gerlach; Giulietta Saletti; Guus F Rimmelzwaan
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

Review 7.  Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy.

Authors:  Andrés Pizzorno; Blandine Padey; Olivier Terrier; Manuel Rosa-Calatrava
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

8.  A model-based assessment of oseltamivir prophylaxis strategies to prevent influenza in nursing homes.

Authors:  Carline van den Dool; Eelko Hak; Marc J M Bonten; Jacco Wallinga
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

Review 9.  Treating Influenza Infection, From Now and Into the Future.

Authors:  Sophia Davidson
Journal:  Front Immunol       Date:  2018-09-10       Impact factor: 7.561

Review 10.  Novel activities of safe-in-human broad-spectrum antiviral agents.

Authors:  Aleksandr Ianevski; Eva Zusinaite; Suvi Kuivanen; Mårten Strand; Hilde Lysvand; Mona Teppor; Laura Kakkola; Henrik Paavilainen; Mira Laajala; Hannimari Kallio-Kokko; Miia Valkonen; Anu Kantele; Kaidi Telling; Irja Lutsar; Pille Letjuka; Natalja Metelitsa; Valentyn Oksenych; Magnar Bjørås; Svein Arne Nordbø; Uga Dumpis; Astra Vitkauskiene; Christina Öhrmalm; Kåre Bondeson; Anders Bergqvist; Tero Aittokallio; Rebecca J Cox; Magnus Evander; Veijo Hukkanen; Varpu Marjomaki; Ilkka Julkunen; Olli Vapalahti; Tanel Tenson; Andres Merits; Denis Kainov
Journal:  Antiviral Res       Date:  2018-04-23       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.